Fatigue and energy changes Fatigue on tirzepatide is common, especially during the initial weeks when caloric intake drops significantly
p = 0.0014), with benefit only seen in patients with atherosclerotic CVD (HR: 0.86
Kleiner DE, Brunt EM, Van Natta M, et al
By reading this article, the reader agrees to indemnify and hold harmless the publisher, content creators, contributors, syndication networks, and all affiliated parties from any and all claims, liabilities, damages, losses, or expensesincluding legal feesarising from the use or misuse of any information or product discussed herein
As GLP-1 utilization expanded, new patient volume for hypertension and high cholesterol therapies declined, with 2024 marking the steepest drop, 3% for hypertension and 4% for high cholesterol
Correlation analysis was performed with corAR1, which describes the within group correlation structure as an autoregressive process of order 1, and accounts for correlation between adjoining observations